TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Scale for Suicidal Ideation (SSI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in CTCAE grading
Endpoint domain: Adverse events/effects
Primary endpoint: Number of steps taken with the device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance walked with the device
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in palpebral gap from the baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in visual acuity (blurred vision) from the baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discomfort of the eyeball and condition of the upper eyelid and facial skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of post-procedural pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of post-procedural pain at day 7 after treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of late post-procedural pain (at day 30 after treatment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of 68Ga-NB381
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Binding Efficiency of 68Ga-NB381
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative amount of sufentanil used
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in cramp severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy on the N-back task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Empathic Tendency Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Form of Perceptions for Caring for Persons with Disabilities
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Program Achievement Test
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: degree of forward head posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hamstring muscles tightness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nearwork-induced transient myopia (NITM) in diopter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of agreement between questionnaires and SCAN examination output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effective dose of remifentanil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safe dose of remifentanil
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of change in balance function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual function communication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Child and Youth Psychological Resilience Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Coping Scale for Adolescents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 3-month Progression-Free Survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Tendon scarring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Negative problems experienced
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: secretory IgA in nasal secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: neutralizing capacity of anti-Spike IgA in nasal secretions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percent of patients completing at least 3 cycles at assigned dose level
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of participants with hospitalisation with progressive COVID-19 symptoms or death
Endpoint domain: Mortality/survival
Primary endpoint: Quality of life related to chemotherapy-induced peripheral neuropathy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: motor symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients requiring pacemaker implantation and/or developing new conduction abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood hs-CRP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of hepatocellular carcinoma diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Stage of hepatocellular carcinoma at diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Correlation of enhancement pattern of delayed USPIO uptake with tissue markers of TAM density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Relationship between volume, pattern and intensity of USPIO imaging and tumour growth status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Association between microvascular parameters from DCE MRI and USPIO imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regression of VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Trials Correct On Working Memory Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brain reactivity to alcohol cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of enrolled participants who complete the treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cumulative water balance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Observed Adverse Events Between the Two Groups
Endpoint domain: Adverse events/effects
Primary endpoint: Days Alive and Out of the Intensive Care Unit (ICU) at 30 Days After Surgery
Endpoint domain: Mortality/survival
Primary endpoint: Post-operative Length of Stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Participant diagnostic accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of motor competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Posture analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of Walking Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility Level Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Perceived Stress Scale (PSS) Total Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Same-day catheter removals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Articulatory gestures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acoustic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Tolerability Events
Endpoint domain: Adverse events/effects
Primary endpoint: Brain tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Surgical skills assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 100-day cumulative II-IV aGVHD incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline in Total Clamp Disposition Index (cDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baseline biomarkers results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dyspnea level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: PGQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Modified Nail Psoriasis Severity Index (mNAPSI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Neurogenic Bladder Symptom Score (NBSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Number of Participants who Discussed Medication Cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average change in daily retrospective total nasal symptom score (rTNSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic Floor Muscle Activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional Connectivity (FC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Oxygenation Level (BOLD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conditioned pain modulation (CPM) and offset analgesia (OA) magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success of aneurysm occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive rate of bacterial contamination of peritoneal washings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Perceived Stress Scale 14 (PSS-14)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of a new clinical relapse
Endpoint domain: Mortality/survival
Primary endpoint: Wound total oxygen saturation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound Size/ Surface Area (cm^2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Analysis of wound pH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of related SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of Damage to Cervix, Uterus or Vagina
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Rate of Occurrence of Uterine Inversion or Folding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Safety of telemonitored sequencing
Endpoint domain: Adverse events/effects
Primary endpoint: Feasibility of telemonitored sequencing
Endpoint domain: Resource use
Primary endpoint: Frequency of Cognitive Screening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of MCI/ADRD, Sleep Disorders, and Depression Diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prescription Rates for Related Medications
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of participants meeting ACR20 response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correlation coefficient between Apnea-Hypopnea Index and overnight change in leg fluid volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: radiographic success of treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical success of treatments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients completing surgical treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hematologic and non-hematologic toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Penetration-Aspiration Scale-liquid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration-Aspiration Scale-paste
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of antibiotic intake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fraction of unselected patients able to undergo day-surgery procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postoperative morbidity Clavien-Dindo
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative morbidity CCI
Endpoint domain: Adverse events/effects
Primary endpoint: Combined Necrotizing enterocolitis or death
Endpoint domain: Mortality/survival
Primary endpoint: Number of participants with an antitumor response
Endpoint domain: Adverse events/effects
Primary endpoint: Two minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30 Second Sit to Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 Minute Sit to Stand Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fourty step walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetes complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of ventilator associated pneumoniae
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical Sensitivity of Buccal Swab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall diagnostic and treatment scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Survivable follicle
Endpoint domain: Mortality/survival
Primary endpoint: Clinician Assessed Changes in VVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Reported VAS Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time of latency for sensory block at T10 dermatome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Depression, and suicidal/self-hurting thoughts
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dementia Care Professional Competency Assessment Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent responders of Clinical Global Impression of Improvement Scale - Partner
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient orientation at discharge
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in frequency of PEM symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of PEM symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in duration of PEM symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of body weight reduction greater than or equal to 5% (Yes/No)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in total corneal staining scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days for weaning from mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: The amount of sputum production per day (ml/day)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: EEG correlates of language reconstitution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Postoperative respiratory depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Area Under the Curve (tAUC) of composite gastrointestinal Symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Safety after UTAA06 injection treatment
Endpoint domain: Adverse events/effects
Primary endpoint: T2-lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve alveolar concentration of sevoflurane at 2%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pelvic floor muscles strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tolerability of VR treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Minimum Active Dose (MAD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory cytokines levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Patient-based PPV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Solicited Acute Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Enamel biopsy for detecting Calcium and Fluoride content
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cornea staining score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: net clinical outcome (composite of all-cause death, MI, TVR, ST, clinically relevant bleeding)
Endpoint domain: Mortality/survival
Primary endpoint: ischemic composite adverse event (all-cause death, MI, TVR, ST)
Endpoint domain: Mortality/survival
Primary endpoint: Concordance of systolic and diastolic BP mean
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change Short-Term Neuroendocrine Stress (Hypothalamic-Pituitary-Adrenal Axis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change Short-Term Immune Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from Baseline Chronic Neuroendocrine Stress (Hypothalamic-Pituitary-Adrenal Axis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: adequate visibility score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Nonstress test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in Schiff sensitivity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary biomarker changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum/plasma biomarker changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool biomarker changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Dermal Blood Flow induced by topical application of cinnamaldehyde
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Dermal Blood Flow induced by topical application of capsaicin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Dermal Blood Flow induced by histamine Skin Prick Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to satisfactory stent placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: 10-year risk of atherosclerotic cardiovascular disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement on Wrinkle Severity Rating Scale (WSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: All-cause and attributed deaths
Endpoint domain: Mortality/survival
Primary endpoint: Major adverse cardiovascular events (MACE) occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Retinal Vessel Diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in asthma control (measured with ACQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline Functional Independence Measure (FIM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Functional drug screen
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of volunteers with increased levels of immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Normalization of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement of hypogonadism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Urine protein/creatinine ratio (UP/C) at week 108
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: PROMIS-29 v2.1 survey score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: WHOQoLBREF survey score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: EQ-5D-3L1 survey score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: composite of incident high-risk varices (HRV), hepatic decompensation or death
Endpoint domain: Mortality/survival
Primary endpoint: Dynamic lung capacities (spirometry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of life assessment using World Health Organization Quality-of-Life Scale (WHOQOL-BREF)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fatigue assessment using modified Borg scale
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Hair regrowth response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of pathological α-synuclein in CSF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes